Keertan Dheda is Professor of Respiratory Medicine, Director of the Lung Infection and Immunity Unit and Head of the Division of Pulmonology, Department of Medicine, at the University of Cape Town.
He has been the recipient of several prestigious awards including: the 2014 SA National Science Technology Forum BHP Billiton awards in the category of contributions to Science, Engineering, and Technology (SET) by an individual through research outputs, the 2014 Oppenheimer Award (one of the most prestigious scientific awards in South Africa), the 2013 MRC Scientific Achievement Award (Gold), the 2010 International Union Against Tuberculosis and Lung Disease Scientific Award, the South African MRC Career Development Award, a South African National Research Foundation and DST Research Chair (SARChI), and holds or has held several multi-national grants as the principal investigator [EU FP7 (TBsusgent, €1 million); EU-funded EDCTP (TB-NEAT, €4.3 million & XACT, € 1 million); NIH R01 (CASS, US$1.5 million), and SA MRC (TB-HART study, R22 million)].
He was recently profiled in The Lancet and The Business Day newspaper.
A specialist Pulmonologist at the University of Cape Town and Groote Schuur Hospital, she graduated from UCT, did her clinical training in Cape Town, London and Manchester and was a Research Fellow both at UCT and at the Royal Free Hospital in London. She is a Past-President of the South African Thoracic Society and the National Asthma Education Programme. She initiated the SA Diploma of Asthma Care for primary health workers in 2002. Her research interests include tuberculosis, interstitial lung disease, major haemoptysis and asthma education.
Greg completed his undergraduate training at the University of Cape Town. After a short stint doing surgery, Greg returned to his alma mater to complete his physician training as well as a 2-year fellowship at GSH and UCT in respiratory and critical care medicine. Thereafter Greg took up a general medical post in the medical wards at Groote Schuur running one of the medical firms. Greg received a Discovery Foundation Academic Fellowship to pursue his interest in drug resistant TB in the lung. Greg’s other interests include infectious diseases and the lung, sleep medicine and lung cancer.
Dr Richard van Zyl-Smit - MBChB, MRCP(UK), Dip HIV(Man), MMED, FCP(SA), Cert Pulm(SA), PhD
Dr Richard van Zyl-Smit is the Head of the Lung Clinical Research Unit (LCRU) at the University of Cape Town Lung Institute. He is head of the smoking cessation services at the E16 Respiratory Clinic at Groote Schuur Hospital as well the head of the adolescent respiratory services. He qualified as a pulmonologist, in 2007 and completed his PhD investigating the effects of tobacco smoke on human pulmonary immune responses to mycobacterial infection in 2011. After a post-doc placement in New York at the end of 2011, he returned to UCT to take up a position at the Lung Institute. He has published in the field of TB diagnostics, specifically interferon gamma release assays and mycobacterial load determination. His current research interests include leading the Lung Clinical Research Unit COPD and Asthma study activities, the interactions of tobacco smoke on immunity, tuberculosis and the development of COPD.
Her interests are particularly in hypertension, having done her PhD in this area. One of the aspects of hypertension that she is studying currently and which is of major concern to nephrologists in Cape Town, is the rising incidence of young hypertensives with end stage renal disease in relation to methamphetamine usage.
Associate Professor Willcox grew up in Rhodesia (Zimbabwe) and graduated from the University of Rhodesia. He went on to train in General Internal Medicine and Pulmonology in the UK and at Groote Schuur Hospital. He has been a consultant in the Respiratory Clinic at Groote Schuur Hospital for over 30 years. He has a wide experience of General Internal Medicine and Pulmonology. His major interests include pulmonary infections particularly tuberculosis. He established the first MDR-TB referral clinic at Brooklyn Chest Hospital in 1982. He is a member of the Western Cape Department of Health Drug Resistant TB Review Board as well as a member of the National Drug Resistant TB Advisory Board. His other interests include cystic fibrosis and he has run the CF clinic at Groote Schuur Hospital since 1989. He is also a member of the Combined Lung Cancer Clinic.
Greg Calligaro completed undergraduate degrees in Medicine and Physiology at the University of the Witwatersrand, and qualified as a specialist physician at the University of Cape Town in 2009. He completed sub-specialist training as a pulmonologist in 2012, and is currently a consultant in the Respiratory Clinic at Groote Schuur Hospital, and a research co-ordinator at the Lung Infection and Immunity Unit. He is working towards a PhD examining aspects of lung health in patients with HIV infection on antiretroviral treatment, as part of an NIH-funded study conducted at the UCT Lung Institute. His research interests include the infectious and non-infectious pulmonary complications of HIV. He is supported by a Discovery Academic Fellowship, an MRC Training Fellowship, and two Pulmonology Research Fellowships from the South African Thoracic Society